2 long-term growth stocks for the intelligent investor

Here's why a2 Milk Company Ltd (Australia) (ASX:A2M) and Sirtex Medical Limited (ASX:SRX) look like a good opportunity right now.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A number of Australia's favourite companies have recently revealed forecasts for limited growth next year. Telstra Corporation Ltd (ASX: TLS)? Close to zero. Medibank Private Ltd (ASX: MPL)? Nada.

Even tech stock Carsales.Com Ltd (ASX: CAR) has been sold off recently, as the market believes single-digit growth will be the norm for it going forwards.

Here are two smaller companies still in their growth phase, that are a much more attractive prospect for growth investors today:

Sirtex Medical Limited (ASX: SRX) is a profitable liver cancer treatment provider currently looking to expand its therapy into other types of cancer. To that end, the company has a number of trials underway, although Research & Development (R&D) expenditure is fairly modest. Treatment dose sales are currently growing at around 15% per annum, and continued sales growth appears likely due to new regulatory approvals and increasing clinical evidence. Sirtex is also considering expanding by acquisition, although I personally am wary of the risk of Sirtex 'diworseifying' or overpaying with this approach.

Sirtex is priced by the market at 30 times last year's earnings, which is a fairly lofty price. We've seen a number of companies including Carsales, CSL Limited (ASX: CSL), and iSentia Group Ltd (ASX: ISD) tumble from similar P/Es after growth slowed. Sirtex will not be immune, but it's tough to find a company with double-digit growth and a clean balance sheet.

A2 Milk Company Ltd (Australia) (ASX:A2M) sells milk with a2 proteins only, which it claims is better for digestion than regular milk which contains both a1 and a2 proteins. Scientific research into evaluating this claim is underway and appears to support it so far. A2 generated most of its initial success in Australia and New Zealand, although recent expansion into China with baby formula has been responsible for the bulk of the company's recent, rapid profit growth.

A2 is also making inroads into two other large target markets in the US and the UK, which should lead to respectable profit growth over the next few years – assuming all goes well. Like Sirtex, a2 Milk comes with a price tag that is currently more than 40 times last year's earnings, although growth remains strong. Also like Sirtex, it carries no debt and has $69 million in cash.

Foolish takeaway

Buying shares in Sirtex and a2 Milk is an implicit bet that both companies can grow profits enough to justify today's prices. With long growth runways ahead and sterling balance sheets, each company appears to have reasonable odds of success. Investors should be sure not to overpay, but here even the market is helping you, with A2 and Sirtex shares volatile recently.

Motley Fool contributor Sean O'Neill owns shares of A2 Milk and Sirtex Medical Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »